← Eichor
Study identifier: NCT06497647 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

New Treatment for Nocturnal Enuresis in Children

Condition: Nocturnal Enuresis in Children  ·  Sponsor: Sohag University

PhaseNA
Planned participants450
Who can joinAll sexes, 6 Years to 18 Years
Healthy volunteersYes

About this study

The aim of the study is to evaluate the role of sulbutiamine in treatment of monosymptomatic nocturnal enuresis in children by using it alone or as a combination therapy with tricyclic antidepressants (imipramine+sulbutiamine).

This description comes directly from the study's public registry record.

Talk to the study team

loai mohammed abd alhamied, resident  ·  01093873434  ·  loaimohamed519@yahoo.com

Always discuss trial participation with your own doctor first.

Locations (1)

Sohag Faculty of MedecineSohag, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06497647